In this issue:
IVIG for ILD of anti-MDA5-positive dermatomyositis
Trial of IVIG in dermatomyositis
Anti-CD19 CAR T cell therapy for refractory SLE
Low dose, add-on prednisolone in patients with RA aged 65+
Autoimmune diseases and cardiovascular risk
Burden of end-stage OA in Australia
Trial of anti-BDCA2 antibody litifilimab for SLE
Tofacitinib treatment for sarcoidosis
Effectiveness of TNFis, abatacept, IL-6is and JAKis in RA
TNFi use during pregnancy and increased birth weight of RA patients’ offspring
Please login below to download this issue (PDF)